3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Anemia, Iron-Deficiency
3
Anemia
2
Stomach Neoplasms
1
Nasopharyngeal Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenocarcinoma
1
Interventions
Docetaxel
5
Pemetrexed
4
Capecitabine
4
pembrolizumab
3
Oxaliplatin
3
icotinib
2
Radiation
2
Paclitaxel
2
Gemcitabine
2
Gefitinib
2
Fluorouracil
2
Drug Therapy
2
Chemoradiotherapy
2
Carboplatin
2
sintilimab
1
rucaparib
1
regorafenib
1
olaparib
1
lenvatinib
1
iron isomaltoside 1000
1
ipatasertib
1
iopromide
1
gluconic acid
1
elemene
1
capecitabine-irinotecan combination
1
aumolertinib
1
atezolizumab
1
anlotinib
1
aflutinib
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Adenocarcinoma
×
iron isomaltoside 1000
×
Clear all
NCT01927328
2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4
Unknown
40 enrolled